| Donald Severinus Gervais Jr, MD | |
|
128 Neuroscience Ct, Gray, LA 70359 | |
| (985) 917-3007 | |
| (985) 917-3010 |
| Full Name | Donald Severinus Gervais Jr |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 29 Years |
| Location | 128 Neuroscience Ct, Gray, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750387676 | NPI | - | NPPES |
| 1697508 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | MD.022617 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Avala | Covington, LA | Hospital |
| Terrebonne General Medical Center | Houma, LA | Hospital |
| Our Lady Of Lourdes Regional Medical Center, Inc | Lafayette, LA | Hospital |
| Park Place Surgical Hospital | Lafayette, LA | Hospital |
| Lafayette Surgical Specialty Hospital | Lafayette, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Neuro Diagnostic Monitoring, Llc | 5698939841 | 3 |
| Southeast Neuroscience Center, Llc | 9032010558 | 7 |
News Archive
Atherosclerosis is a disease defined by the accumulation of fatty deposits called plaques inside the arteries. It is a leading cause of heart attacks and strokes.
People who are 30 pounds or more overweight may want to slim down a bit even if they don't have high blood pressure or any other heart disease risk, according to scientists at Wake Forest Baptist Medical Center.
Seattle Genetics, Inc. today announced that Genentech, Inc., a wholly owned member of the Roche Group, will pay $9.5 million to renew exclusive licenses to specific targets and extend the research term under the parties' existing antibody-drug conjugate (ADC) collaboration agreement. Under the terms of the agreement, Genentech has rights to use Seattle Genetics' ADC technology with antibodies against targets selected by Genentech.
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced that it will launch six new orthopaedic textbooks at this year's American Academy of Orthopaedic Surgeons conference taking place at the Orange County Convention Center, West Building, Orlando, FL, March 1-5, 2016.
› Verified 7 days ago
| Entity Name | Southeast Neuroscience Center, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285630129 PECOS PAC ID: 9032010558 Enrollment ID: O20040505000063 |
News Archive
Atherosclerosis is a disease defined by the accumulation of fatty deposits called plaques inside the arteries. It is a leading cause of heart attacks and strokes.
People who are 30 pounds or more overweight may want to slim down a bit even if they don't have high blood pressure or any other heart disease risk, according to scientists at Wake Forest Baptist Medical Center.
Seattle Genetics, Inc. today announced that Genentech, Inc., a wholly owned member of the Roche Group, will pay $9.5 million to renew exclusive licenses to specific targets and extend the research term under the parties' existing antibody-drug conjugate (ADC) collaboration agreement. Under the terms of the agreement, Genentech has rights to use Seattle Genetics' ADC technology with antibodies against targets selected by Genentech.
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced that it will launch six new orthopaedic textbooks at this year's American Academy of Orthopaedic Surgeons conference taking place at the Orange County Convention Center, West Building, Orlando, FL, March 1-5, 2016.
› Verified 7 days ago
| Entity Name | Neuro Diagnostic Monitoring, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598030181 PECOS PAC ID: 5698939841 Enrollment ID: O20120619000630 |
News Archive
Atherosclerosis is a disease defined by the accumulation of fatty deposits called plaques inside the arteries. It is a leading cause of heart attacks and strokes.
People who are 30 pounds or more overweight may want to slim down a bit even if they don't have high blood pressure or any other heart disease risk, according to scientists at Wake Forest Baptist Medical Center.
Seattle Genetics, Inc. today announced that Genentech, Inc., a wholly owned member of the Roche Group, will pay $9.5 million to renew exclusive licenses to specific targets and extend the research term under the parties' existing antibody-drug conjugate (ADC) collaboration agreement. Under the terms of the agreement, Genentech has rights to use Seattle Genetics' ADC technology with antibodies against targets selected by Genentech.
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced that it will launch six new orthopaedic textbooks at this year's American Academy of Orthopaedic Surgeons conference taking place at the Orange County Convention Center, West Building, Orlando, FL, March 1-5, 2016.
› Verified 7 days ago
| Entity Name | Neurotech Of Louisiana Llc |
|---|---|
| Entity Type | Part B Supplier - Independent Diagnostic Testing Facility (idtf) |
| Entity Identifiers | NPI Number: 1598001794 PECOS PAC ID: 5294057642 Enrollment ID: O20141215000314 |
News Archive
Atherosclerosis is a disease defined by the accumulation of fatty deposits called plaques inside the arteries. It is a leading cause of heart attacks and strokes.
People who are 30 pounds or more overweight may want to slim down a bit even if they don't have high blood pressure or any other heart disease risk, according to scientists at Wake Forest Baptist Medical Center.
Seattle Genetics, Inc. today announced that Genentech, Inc., a wholly owned member of the Roche Group, will pay $9.5 million to renew exclusive licenses to specific targets and extend the research term under the parties' existing antibody-drug conjugate (ADC) collaboration agreement. Under the terms of the agreement, Genentech has rights to use Seattle Genetics' ADC technology with antibodies against targets selected by Genentech.
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced that it will launch six new orthopaedic textbooks at this year's American Academy of Orthopaedic Surgeons conference taking place at the Orange County Convention Center, West Building, Orlando, FL, March 1-5, 2016.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Donald Severinus Gervais Jr, MD Po Box 1930, Gray, LA 70359-1930 Ph: (985) 917-3007 | Donald Severinus Gervais Jr, MD 128 Neuroscience Ct, Gray, LA 70359 Ph: (985) 917-3007 |
News Archive
Atherosclerosis is a disease defined by the accumulation of fatty deposits called plaques inside the arteries. It is a leading cause of heart attacks and strokes.
People who are 30 pounds or more overweight may want to slim down a bit even if they don't have high blood pressure or any other heart disease risk, according to scientists at Wake Forest Baptist Medical Center.
Seattle Genetics, Inc. today announced that Genentech, Inc., a wholly owned member of the Roche Group, will pay $9.5 million to renew exclusive licenses to specific targets and extend the research term under the parties' existing antibody-drug conjugate (ADC) collaboration agreement. Under the terms of the agreement, Genentech has rights to use Seattle Genetics' ADC technology with antibodies against targets selected by Genentech.
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced that it will launch six new orthopaedic textbooks at this year's American Academy of Orthopaedic Surgeons conference taking place at the Orange County Convention Center, West Building, Orlando, FL, March 1-5, 2016.
› Verified 7 days ago
Edward Stewart Haight, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 128 Neuroscience Ct, Gray, LA 70359 Phone: 985-917-3007 Fax: 985-447-4209 |